Initial experience with fenoldopam in children

American Journal of Therapeutics

Volumn 6, Issue 5, 1999, Pages 283-288

  Strauser, Lynne M ^a   Pruitt, Roger D ^a   Tobias, Joseph D ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

Controlled hypotension; Fenoldopam; Hypertension

Indexed keywords

FENOLDOPAM;

ARTERY DILATATION; ARTICLE; CASE REPORT; CHILD; DRUG EXPOSURE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; INFANT; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL;

EID: 0032854473     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199909000-00007     Document Type: Article

References (17)

1. Groshong T: Hypertensive crisis in children. Pediatr Ann 1996;25:369-376.
2. Testa L, Tobias JD: Pharmacologic agents for controlled hypotension. J Clin Anesth 1995;7:326-337.
3. Sinaiko AR: Hypertension in children. N Engl J Med 1996;335:1968-1973.
4. Post JB IV, Frishman WH: Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies. J Clin Pharmacol 1998;38:2-13.
5. Alison NL, Dubb JW, Ziemniak JA, et al: The effect of fenoldopam, a dopaminergic agonist on renal hemodynamics. Clin Pharmacol Ther 1987;41:282-288.
6. Weber RR, McCoy CE, Ziemniak JD, et al: Pharmacokinetics and pharmacodynamic properties of intravenous fenoldopam. Br J Clin Pharmacol 1988;25:17-21.
7. Bednarczyk EM, White WB, Munger MA, et al: Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe hypertension. Am J Cardiol 1989;63:993-996.
8. Pilmer BL, Green JA, Panacek EA, et al: Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension. J Clin Pharmacol 1993;33:549-553.
9. Panacek EA, Bednarczyk EM, Dunbar LM, et al: Randomized, prospective trial of fenoldopam versus sodium nitroprusside in the treatment of acute severe hypertension. Acad Emerg Med 1995;2:959-965.
10. Elliott WJ, Weber RR, Nelson KS, et al: Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation 1990;81: 970-977.
11. Shusterman NH, Elliott WJ, White WB: Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med 1993;95:161-168.
12. Everitt DE, Boike SC, Piltz-Seymour JR, et al: Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension. J Clin Pharmacol 1997;37:312-320.
13. Tobias JD: Nicardipine: applications in anesthesia practice. J Clin Anesth 1995;7:525-533.
14. Michael J, Groshong T, Tobias JD: Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 1998;12:40-42.
15. Tobias JD, Hersey S, Mencio GA, Green NE: Nicardipine for controlled hypotension during spinal surgery. J Pediatr Orthop 1996;16:370-373.
16. Fahmy NR: Nitroglycerin as a hypotensive drug during general anesthesia. Anesthesiology 1978;49:17-20.
17. Yaster M, Simmons RS, Tolo VT, et al: A comparison of nitroglycerin and nitroprusside for inducting hypotension in children: a double blind study. Anesthesiology 1986;65:175-179.